Cargando…
Personalised Medicine with IL-23 Blockers: Myth or Reality?
BACKGROUND AND AIMS: The medical management of inflammatory bowel disease [IBD] has become increasingly targeted, through the identification of specific immune mediators involved in its pathogenesis. IL-23 is an inflammatory cytokine involved in both innate and adaptive immunity, which has been iden...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113162/ https://www.ncbi.nlm.nih.gov/pubmed/35553661 http://dx.doi.org/10.1093/ecco-jcc/jjab190 |